Literature DB >> 20200170

When and how to evaluate mildly elevated liver enzymes in apparently healthy patients.

George Aragon1, Zobair M Younossi.   

Abstract

Because 1% to 9% of people without symptoms have elevated liver enzymes, extensive evaluation of all abnormal test results would expose many patients to undue risks and expenses. On the other hand, failure to evaluate minor liver enzyme elevations could mean missing the early diagnosis of potentially treatable disorders. This review discusses likely causes of elevated aminotransferase, alkaline phosphatase, and gamma-glutamyl transferase levels and provides algorithms for evaluating high liver enzyme values in apparently healthy patients in the primary care setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200170     DOI: 10.3949/ccjm.77a.09064

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  31 in total

1.  73-year-old man with increasing abdominal girth and dyspnea.

Authors:  Sara L Reppert; Christopher M Wittich
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

2.  Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males.

Authors:  Gary A Herman; Goutam C Mistry; Bingming Yi; Arthur J Bergman; Amy Q Wang; Wei Zeng; Li Chen; Karen Snyder; Jon L Ruckle; Patrick J Larson; Michael J Davies; Ronald B Langdon; Keith M Gottesdiener; John A Wagner
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  Serum carbohydrate deficient transferrin as a sensitive marker in diagnosing alcohol abuse: a case control study.

Authors:  Teena Thomas; Jayadevan Sreedharan
Journal:  J Clin Diagn Res       Date:  2013-11-10

4.  Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice.

Authors:  Krishna Kattel; Goutam Mondal; Feng Lin; Virender Kumar; Ram I Mahato
Journal:  Mol Pharm       Date:  2016-11-07       Impact factor: 4.939

5.  Blood markers of alcohol use in epistaxis patients.

Authors:  Michael B Soyka; Thomas Schrepfer; David Holzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-21       Impact factor: 2.503

6.  Growth, serum biochemical, and histopathological responses of broilers administered with silver nanoparticles as a drinking water disinfectant.

Authors:  Indrajeet Kumar; Jayanta Bhattacharya; Bidus Kanti Das; Pooja Lahiri
Journal:  3 Biotech       Date:  2020-02-05       Impact factor: 2.406

7.  A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?

Authors:  Shinichiro Takao; Kosuke Tanaka; Masayuki Miyazaki; Masatake Tanaka; Tomoko Ohashi; Masaki Kato; Kazuhiro Kotoh; Shinichi Aishima; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2013-07-28

8.  Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.

Authors:  Wei Perng; Ellen C Francis; Harry A Smith; John Carey; Dongqing Wang; Katerina M Kechris; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

9.  Curcumin Attenuates Hepatotoxicity Induced by Zinc Oxide Nanoparticles in Rats.

Authors:  Layasadat Khorsandi; Esrafil Mansouri; Mahmoud Orazizadeh; Zahra Jozi
Journal:  Balkan Med J       Date:  2016-05-01       Impact factor: 2.021

Review 10.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.